Literature DB >> 4547395

Reduction in the severity of Mycoplasma pneumoniae-induced pneumonia in hamsters by immunosuppressive treatment with antithymocyte sera.

G Taylor, D Taylor-Robinson, G W Fernald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4547395     DOI： 10.1099/00222615-7-3-343

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


× No keyword cloud information.
  18 in total

1.  Interferon gamma and interleukin 4 have contrasting effects on immunopathology and the development of protective adaptive immunity against mycoplasma respiratory disease.

Authors:  Sheetal Bodhankar; Xiangle Sun; Matthew D Woolard; Jerry W Simecka
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

2.  Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice.

Authors:  G Taylor; D Taylor-Robinson
Journal:  Immunology       Date:  1976-05       Impact factor: 7.397

3.  NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp.

Authors:  Matthew D Woolard; Dorothy Hudig; Leslie Tabor; James A Ivey; Jerry W Simecka
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  THE MULTIFACETED ROLE OF T CELL-MEDIATED IMMUNITY IN PATHOGENESIS AND RESISTANCE TO MYCOPLASMA RESPIRATORY DISEASE.

Authors:  Nicole A Dobbs; Adam N Odeh; Xiangle Sun; Jerry W Simecka
Journal:  Curr Trends Immunol       Date:  2009

5.  Hemadsorption and virulence are separable properties of Mycoplasma pneumoniae.

Authors:  D K Leith; E J Hansen; R M Wilson; D C Krause; J B Baseman
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

6.  Cytokine and chemokine transcription profile during Mycoplasma pulmonis infection in susceptible and resistant strains of mice: macrophage inflammatory protein 1beta (CCL4) and monocyte chemoattractant protein 2 (CCL8) and accumulation of CCR5+ Th cells.

Authors:  Xiangle Sun; Harlan P Jones; Lisa M Hodge; Jerry W Simecka
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

7.  NK cells interfere with the generation of resistance against mycoplasma respiratory infection following nasal-pulmonary immunization.

Authors:  Sheetal Bodhankar; Mathew D Woolard; Xiangle Sun; Jerry W Simecka
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

8.  Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.

Authors:  Ana María Ríos; Asunción Mejías; Susana Chávez-Bueno; Mónica Fonseca-Aten; Kathy Katz; Jeanine Hatfield; Ana María Gómez; Hasan S Jafri; George H McCracken; Octavio Ramilo; Robert Doug Hardy
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

Review 9.  The use of organ cultures and animal models in the study of Mycoplasma pneumoniae infections.

Authors:  D Taylor-Robinson
Journal:  Infection       Date:  1976       Impact factor: 3.553

10.  Attempts to produce granulomatous colitis in Boxer dogs with a mycoplasma.

Authors:  P S Bowe; H J Van Kruiningen; S Rosendal
Journal:  Can J Comp Med       Date:  1982-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.